Njbio India Pharmaceutical Private Limited

Njbio India Pharmaceutical Private Limited - travel and hospitality in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN U73100MH2019PTC319319 Incorporated 10 January 2019 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company travel and hospitality
Data last updated
Revenue · FY 2025
₹15.2 Cr
▼ 1.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹20 Cr
Registered with MCA
Paid-up capital
₹16.37 Cr
Issued & subscribed
Open charges
None
Satisfied ₹8.16 Cr
Company age
7 yrs
Est. 2019
Employees · EPFO
38
Latest available

About Njbio India Pharmaceutical Private Limited

Data last updated: 17 December 2025

Njbio India Pharmaceutical Private Limited is a private limited company based in Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It specialises in consumer and professional services, a part of the broader travel and hospitality sector. Incorporated on 10 January 2019, the company has been in operation for over 7 years.

Registered with ROC Mumbai under CIN U73100MH2019PTC319319.

Capital: an authorised share capital of ₹20 Cr and a paid-up capital of ₹16.37 Cr. Formerly known as Amar Chemistry Private Limited. It is led by directors including Arpit Pokharna and Rahul Suresh Bagul.

Last AGM: 22 August 2025. Financial statements filed for year ended 31 March 2025. Office: 1A Ground Floor Ackruti Corporate Park, Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹15.2 Cr, a decline of 1% compared to the previous year.

The company has a workforce of approximately 38 employees as per the latest available data.

The company is associated with 1 brand - Amar Chemistry. As per MCA filings, the company has satisfied charges of ₹8.16 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website amarchemistry.com.

Company Details of Njbio India Pharmaceutical Private Limited
CIN U73100MH2019PTC319319
Registration Number 319319
Incorporation Date 10 January 2019
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 22 August 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    G – 1 G – 1A Ground Floor Ackruti Corporate Park Cts No 586 586/1 Lbs Marg Kanjur Village, Bhandup W, Mumbai, Maharashtra, India – 400078
  • Industry
    Travel and Hospitality, Consumer Professional Services
Company report
Njbio India Pharmaceutical Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Njbio India Pharmaceutical Private Limited report

Financials, compliance, directors, charges, ownership and filings for Njbio India Pharmaceutical Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Njbio India Pharmaceutical Private Limited

Njbio India Pharmaceutical Private Limited operates one associated brand: Amar Chemistry. These brands represent Njbio India Pharmaceutical Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Manufactures a range of chemical products, including sodium metabisulfite powder, sodium bisulphites, and sodium sulfite powder. amarchemistry.com

Business Activity of Njbio India Pharmaceutical Private Limited

Njbio India Pharmaceutical Private Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including scientific research and development.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
M Professional, Scientific and Technical M5 Scientific research and development Locked
Premium access

Business activity turnover details for Njbio India Pharmaceutical Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Njbio India Pharmaceutical Private Limited

Njbio India Pharmaceutical Private Limited is audited by Sheth Doshi & Associates for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
Sheth Doshi & Associates Locked Locked Locked
Premium access

Complete auditor history for Njbio India Pharmaceutical Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Njbio India Pharmaceutical Private Limited

Njbio India Pharmaceutical Private Limited is currently managed by 3 directors, with 5 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Arpit Pokharna Director 01 Sep 2023 2 Years 10 Months Current
Rahul Suresh Bagul Whole-Time Director 16 Dec 2024 1 Years 7 Months Current
Nareshkumar Fulchand Jain Director 10 Jan 2019 7 Years 6 Months Current

Financials of Njbio India Pharmaceutical Private Limited FY 2025 filings available

Njbio India Pharmaceutical Private Limited reported revenue of ₹15.2 Cr (down 1.00% YoY) for FY 2025.

Revenue · FY 2025
₹15.2 Cr ▼ 1.00%
Premium access

Ten-year financial statements for Njbio India Pharmaceutical Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Njbio India Pharmaceutical Private Limited

Premium access

Shareholding and ownership data for Njbio India Pharmaceutical Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Njbio India Pharmaceutical Private Limited

Open charges
₹0
Satisfied charges
₹8.16 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹8.16 Cr
Latest charge details
DateLenderAmountStatus
20 Aug 2019 Hdfc Bank Limited ₹8.16 Cr Satisfied

Total charge records: 1 View all charges

Employees and EPFO Compliance at Njbio India Pharmaceutical Private Limited

Njbio India Pharmaceutical Private Limited has a workforce of 38 employees as of Apr 05, 2024.

Employee count
38
Active EPFO establishments
1
Employee growth
26.67%
Premium access

Employee and EPFO history for Njbio India Pharmaceutical Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Njbio India Pharmaceutical Private Limited

Premium access

GST registrations and filing compliance for Njbio India Pharmaceutical Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Njbio India Pharmaceutical Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Njbio India Pharmaceutical Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Njbio India Pharmaceutical Private Limited

Premium access

MSME payment history for Njbio India Pharmaceutical Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Njbio India Pharmaceutical Private Limited

Premium access

Corporate group structure for Njbio India Pharmaceutical Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Njbio India Pharmaceutical Private Limited

Premium access

MCA filings and documents for Njbio India Pharmaceutical Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Njbio India Pharmaceutical Private Limited

Directors
12 Sep 2025
Tanveer Fatima was appointed as a Company Secretary on 12 Sep 2025 & has been associated with this company since 10 months 15 days.
Activity
22 Aug 2025
Njbio India Pharmaceutical Private Limited last Annual general meeting of members was held on 22 Aug 2025 as per latest MCA records.
Directors
03 Jul 2025
Swati Mathur was appointed as a Cfo on 03 Jul 2025 & has been associated with this company since 1 year 25 days.
Activity
31 Mar 2025
Njbio India Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Directors
16 Dec 2024
Rahul Suresh Bagul was appointed as a Whole-time director on 16 Dec 2024 & has been associated with this company since 1 year 7 months.
Directors
01 Sep 2023
Arpit Pokharna was appointed as a Director on 01 Sep 2023 & has been associated with this company since 2 years 10 months.

Frequently Asked Questions about Njbio India Pharmaceutical Private Limited

Njbio India Pharmaceutical Private Limited is an active private limited company in the travel and hospitality sector based in Mumbai, Maharashtra, India. It was incorporated on 10 January 2019 (7+ years old) and is registered under CIN U73100MH2019PTC319319. The company has 38 employees.

Njbio India Pharmaceutical Private Limited reported revenue of ₹15.2 Cr for FY 2025 (down 1.00% YoY).

The current directors of Njbio India Pharmaceutical Private Limited are:

The primary industry of Njbio India Pharmaceutical Private Limited is travel and hospitality. The company specifically operates in consumer professional services. The company is currently active in this sector.

Yes, Njbio India Pharmaceutical Private Limited is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Njbio India Pharmaceutical Private Limited can be reached at the registered office: G – 1 G – 1A Ground Floor Ackruti Corporate Park Cts No 586 5861 Lbs Marg Kanjur Village, Bhandup W, Mumbai, Maharashtra, India – 400078, or through the website amarchemistry.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available